Using ctDNA to Monitor Patients With Melanoma

Source: cancer network, October 2021

John Kirkwood, MD, PhD: There are 2 arenas. First, the measurable active disease where we can make correlations much quicker because those patients have radiologically assessable or palpable disease.

READ THE ORIGINAL FULL ARTICLE